A. Khasanova

The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia

E. Imyanitov, R. Zukov, A. Iyevleva, 2021 .

Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study

L. Bolotina, M. Fael, E. Kovalenko, 2021, Meditsinskiy sovet = Medical Council.

The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia

L. Bolotina, V. Gorbunova, S. Limareva, 2016 .

FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma

L. Demidov, I. Tsimafeyeu, D. Khochenkov, 2017, Clinical and Translational Oncology.

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study

F. Moiseenko, O. Kit, D. Nosov, 2019, Medical Council.